Glycogen synthase kinase 3β as a potential therapeutic target in synovial sarcoma and fibrosarcoma

Soft tissue sarcomas (STSs) are a rare cancer type. Almost half are unresponsive to multi‐pronged treatment and might therefore benefit from biologically targeted therapy. An emerging target is glycogen synthase kinase (GSK)3β, which is implicated in various diseases including cancer. Here, we inves...

Descripción completa

Detalles Bibliográficos
Autores principales: Abe, Kensaku, Yamamoto, Norio, Domoto, Takahiro, Bolidong, Dilireba, Hayashi, Katsuhiro, Takeuchi, Akihiko, Miwa, Shinji, Igarashi, Kentaro, Inatani, Hiroyuki, Aoki, Yu, Higuchi, Takashi, Taniguchi, Yuta, Yonezawa, Hirotaka, Araki, Yoshihiro, Aiba, Hisaki, Minamoto, Toshinari, Tsuchiya, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004542/
https://www.ncbi.nlm.nih.gov/pubmed/31808966
http://dx.doi.org/10.1111/cas.14271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004542/
https://www.ncbi.nlm.nih.gov/pubmed/31808966
http://dx.doi.org/10.1111/cas.14271

Ejemplares similares